The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2U INC | COM | 90214J101 | 39,254 | 2,594,620 | SH | DFND | 1 | 2,594,620 | 0 | 0 | |
OVASCIENCE INC | COM | 69014Q101 | 21,935 | 2,392,034 | SH | DFND | 1 | 2,392,034 | 0 | 0 | |
CERULEAN PHARMA INC | COM | 15708Q105 | 880 | 168,580 | SH | DFND | 1 | 168,580 | 0 | 0 | |
VERASTEM INC | COM | 92337C104 | 10,785 | 1,190,358 | SH | DFND | 1 | 1,190,358 | 0 | 0 | |
WIX COM LTD | SHS | M98068105 | 157,450 | 7,935,978 | SH | DFND | 1 | 7,935,978 | 0 | 0 | |
CRITEO S A | SPONS ADS | 226718104 | 118,145 | 3,498,513 | SH | DFND | 1 | 3,498,513 | 0 | 0 | |
ACCELERON PHARMA INC | COM | 00434H108 | 5,947 | 175,075 | SH | DFND | 1 | 175,075 | 0 | 0 |